F19.18
Other psychoactive substance abuse with other psychoactive substance-induced disorders
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.18 refers to a specific category of substance use disorder characterized by the abuse of psychoactive substances other than alcohol, opioids, or cannabis, combined with other mental health disturbances caused by these substances. This diagnosis applies when an individual experiences a combination of substance misuse alongside additional mental or physical health conditions induced by the psychoactive substances. These disorders can significantly impact a person’s overall well-being, functioning, and quality of life, often requiring comprehensive assessment and intervention.
Causes & Symptoms
Clinical Causes: Repeated use of psychoactive substances, which alter brain chemistry and influence behavior. Psychological factors, such as stress, trauma, or mental health conditions, that increase vulnerability to substance misuse. Environmental influences, including peer pressure, availability of substances, and social circumstances. Genetic predisposition or family history of substance abuse or mental health disorders. Misuse of prescription medications or recreational substances that produce psychoactive effects.
Key Symptoms: Strong cravings or urges to use the psychoactive substance. Unsuccessful attempts to reduce or stop substance use. Neglect of responsibilities at work, school, or home due to substance-related activities. Changes in mood or behavior, such as irritability, anxiety, or depression. Physical signs of substance use, such as tremors, sweating, or dilated pupils. Sleep disturbances, including insomnia or excessive drowsiness. Impaired social relationships and withdrawal from usual activities. Development of additional mental health symptoms, like hallucinations, paranoia, or confusion, related to substance effects.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves thorough medical and psychological evaluations, including patient history, physical examination, and screening tools tailored to detect substance use and related mental health issues. Healthcare providers may utilize laboratory tests, such as blood or urine analyses, to confirm recent substance intake. Diagnostic criteria focus on identifying ongoing patterns of psychoactive substance abuse, the presence of related mental health disturbances, and their impact on daily functioning. It is essential to differentiate between substance abuse and dependence for accurate diagnosis and treatment planning.
Treatment Protocols: Management of conditions coded as F19.18 typically involves a multidisciplinary approach, including behavioral therapies, counseling, and support groups. Pharmacological interventions may be used to address specific symptoms or co-occurring mental health disorders, although they are tailored to individual needs. Treatment goals focus on reducing substance use, managing mental health symptoms, preventing relapses, and promoting long-term recovery. Ongoing monitoring and support are vital to help individuals sustain sobriety and improve overall functioning.
Clinical Advice & FAQs
Billing Guidance
Is F19.18 a billable ICD-10 code?
Yes, F19.18 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.18?
Clinical documentation must specify the nature of Other psychoactive substance abuse with other psychoactive substance-induced disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
